Details for Patent: 8,765,153
✉ Email this page to a colleague
Which drugs does patent 8,765,153 protect, and when does it expire?
Patent 8,765,153 protects XOPENEX HFA and is included in one NDA.
This patent has thirty-six patent family members in eighteen countries.
Summary for Patent: 8,765,153
| Title: | Levalbuterol salt |
| Abstract: | Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler. |
| Inventor(s): | McGlynn; Paul (Marlborough, MA), Bakale; Roger (Shrewsbury, MA), Sturge; Craig (Falmouth, CA) |
| Assignee: | |
| Application Number: | 13/873,084 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 8,765,153
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | XOPENEX HFA | levalbuterol tartrate | AEROSOL, METERED;INHALATION | 021730-001 | Mar 11, 2005 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,765,153
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 324364 | ⤷ Try a Trial | |||
| Austria | 498604 | ⤷ Try a Trial | |||
| Australia | 2003295695 | ⤷ Try a Trial | |||
| Canada | 2507572 | ⤷ Try a Trial | |||
| Cyprus | 1111330 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
